What's New Archives

News Release: Pediatricians Applaud Pediatric Drug, Device Legislation Passage more

Press Statement on House Pediatric Drug Legislation - By Jay E. Berkelhamer, MD, FAAP, AAP President more

FDA issues Public Health Advisory on the Use of Nonprescription Cough and Cold Products in Children more

AAP Testimony presented before the House Committee on Energy and Commerce Subcommittee on Health regarding the Best Pharmaceuticals for Children Act and Pediatric Research Equity Act more

U.S. Reviewing Safety of Children's Cough Drugs (New York Times, March 2, 2007) more

New Report on Sedation Monitoring and Management Released by AAP and the American Academy of Pediatric Dentistry more

Academy endorses principles for sound drug formularies more

AAP/COID releases new policy on The Use of Systemic Fluroquinolones more

AAP offers evidence-based recommendations for diagnosing, treating bronchiolitis in infants more

AHRQ seeks nominations for Effective Health Care Stakeholder Group more

FDA Panel recommends black box warning on ADHD stimulant medications more

Delphi Survey Executive Summary more

Issues Surrounding Pediatric Drug Labeling - Read the Executive Summary of Periodic Survey #62 more

FDA Joins Children's Health Groups to Mark Historic Milestone for Pediatric Drugs - 100 Drug Labels Have New Pediatric Information Since 1997 more

AAP Testimony on ADHD Medications presented to the FDA Pediatric Advisory Committee, March 22, 2006 more

Questions and Answers: Safety of Pills for Treating ADHD - Common questions from parents more